Medical

搜索文档
STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025
Globenewswire· 2025-07-23 04:30
DUBLIN, IRELAND, July 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 first quarter results at 9:00 a.m. ET on August 7, 2025. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing financial results will be issued after ...
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025
Globenewswire· 2025-07-23 04:05
About OrthoPediatrics Corp. WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2025 financial results on August 5, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 5, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in liste ...
Sanuwave Health to Present at Canaccord Genuity Growth Conference
Globenewswire· 2025-07-23 04:05
EDEN PRAIRIE, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, FDA-approved wound care products , today announced, that Morgan Frank, Chief Executive Officer, will present at the 45th Annual Canaccord Genuity Growth Conference, being held August 12–13, 2025, at the InterContinental Hotel in Boston, Massachusetts. Sanuwave’s group presentation is scheduled for Wednesday, August 13, from 9:30 to 9:55 a.m. ET. In addition to the presentation, ...
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
Globenewswire· 2025-07-23 04:05
About CeriBell, Inc. SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the second quarter of 2025 after the close of trading on Tuesday, August 5, 2025. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on A ...
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025
Globenewswire· 2025-07-23 04:05
About Axogen Axogen (AXGN) is the leading Company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide th ...
WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up?
ZACKS· 2025-07-23 01:16
Key Takeaways WST expects Q2 revenues of $720M-$730M and EPS of $1.50-$1.55, with organic sales up 3%-4%. WST's Proprietary Products segment is set to grow 4.6%, led by GLP-1 demand and SmartDose platform gains. WST's Contract Manufacturing gains from GLP-1 injectors as CGM volume winds down and new projects ramp.West Pharmaceutical Services (WST) is scheduled to release second-quarter 2025 results on July 24, before the opening bell. In the last reported quarter, the company delivered an earnings beat of ...
Why Halozyme Therapeutics (HALO) is Poised to Beat Earnings Estimates Again
ZACKS· 2025-07-23 01:11
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Halozyme Therapeutics (HALO) , which belongs to the Zacks Medical - Biomedical and Genetics industry.When looking at the last two reports, this biopharmaceutical company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 12.73%, on average, in the last two quarters.For the most recent quarter, Halozyme Therapeut ...
Mesoblast Limited (MESO) Is Up 40.59% in One Week: What You Should Know
ZACKS· 2025-07-23 01:01
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Even though momentum is a popular stock charact ...
Pre-Markets Marginally Higher on Q2 Earnings
ZACKS· 2025-07-23 00:01
Pre-market futures are inching higher once again this morning. We are devoid major economic reports ahead of today's open, but have plenty of quarterly earnings results, as you can see below. The Dow and the S&P 500 are both currently up +9 points, while the Nasdaq is +4 points. Bond yields continue to shrink away: +4.36% on the 10-year, +3.84% on the 2-year, and it look like we'll once again stop talking about the 30-year bond yield, which is down to +4.94%. Biggest Q2 Earnings Morning Thus Far So many imp ...
Earnings Beats for GM, DHI, KO, etc. Lead Pre-Markets Slightly Higher
ZACKS· 2025-07-22 23:21
市场表现 - 道指和标普500指数均上涨9点 纳斯达克指数上涨4点 [1] - 10年期国债收益率降至4.36% 2年期降至3.84% 30年期降至4.94% [1] 汽车行业 - 通用汽车(GM)Q2每股收益2.53美元超预期5.86% 营收479.8亿美元超预期1.89% [2] - 北美地区息税前利润(EBIT)低于预期 股价下跌1.8% [2] 国防工业 - 洛克希德马丁(LMT)Q2每股收益7.29美元超预期12.33% 但182亿美元营收低于预期 股价下跌7% [3] - 诺斯罗普格鲁曼(NOC)Q2每股收益7.11美元超预期5.96% 营收超预期2.94% 股价上涨3% [3] 房地产行业 - D.R. Horton(DHI)Q3每股收益3.36美元超预期15.86% 营收92.3亿美元超预期5.13% 股价上涨6% [4] - 公司股价过去一年累计下跌25% 本次上涨部分收复失地 [4] 消费品行业 - 可口可乐(KO)Q2每股收益0.87美元超预期 但125.4亿美元营收低于预期0.44% 股价小幅下跌 [5] - 公司股价年初至今仍累计上涨12% [5] - 宣伟(SHW)Q2每股收益3.38美元低于预期10.11% 营收63.1亿美元超预期0.49% 股价下跌4% [6] - 公司股价年初至今转为负收益 [6] 科技与金融行业 - 德州仪器(TXN)预计Q2利润和营收将实现两位数增长 [7] - Capital One(COF)预计利润和营收增长均超过20% [7] - Intuitive Surgical(ISRG)预计利润增长8% 营收增长16.8% [7]